Journal of Clinical Investigation 116, 984-995CrossRefGoogle ScholarPubMed 81Hirayama, A., Yoh, K., Nagase, S
TESTON OFFICIALLY TAKES THE HELM AS FDA DIRECTOR GENERAL, VOWS TO RESTORE PUBLIC TRUST AND STRENGTHEN THE AGENCYS SERVICE TO THE NATION 15 May 2025 Alabang, Muntinlupa City May 13, 2025 The Food and Drug Administration (FDA) of the Philippines welcomed its
BPC-157 and TB-500 are among the most studied peptides in this space
& Steinberg, D
Component-Level Trial Findings CJC-1295 (without DAC, modified GRF 1-29) Phase 1 and Phase 2 work described: Dose-dependent GH elevation (2-10x baseline at studied doses, PMID 16352683) IGF-1 elevation of 1.5-3x baseline at 1-2 weeks Mild facial flushing post-injection in some participants No serious adverse events at studied doses CJC-1295 with DAC The DAC-modified version covalently binds to albumin, extending half-life to 5-8 days (PMID 16352683)
Alzoubi KH, Al-Dekah AM, Jaradat S, Alrabadi N (2022) L-Carnitine prevents memory impairment induced by post-traumatic stress disorder